Have a personal or library account? Click to login
Review of Hereditary and Acquired Rare Choreas Cover

Review of Hereditary and Acquired Rare Choreas

Tremor and Other Hyperkinetic Movements
Volume 10 (2020): Issue 0
By: Daniel Martinez-Ramirez,  Ruth H. Walker,  Mayela Rodriguez-Violante,  Emilia M. Gatto and  on behalf of the Rare Movement Disorders Study Group of International Parkinson’s Disease and Movement Disorders Society  
Open Access
|Aug 2020

References

  1. 1Hermann A, Walker RH. Diagnosis and treatment of chorea syndromes. Current neurology and neuroscience reports. 2015; 15: 514. DOI: 10.1007/s11910-014-0514-0
    Back to article
  2. 2Burnett L, Jankovic J. Chorea and ballism. Curr Opin Neurol Neurosurg. 1992; 5: 308–13.
    Back to article
  3. 3Termsarasab P. Chorea. Continuum (Minneap Minn). 2019; 25: 1001–35. DOI: 10.1212/CON.0000000000000763
    Back to article
  4. 4Mestre TA. Chorea. Continuum (Minneap Minn). 2016; 22: 1186–207. DOI: 10.1212/CON.0000000000000349
    Back to article
  5. 5Olgiati S, Quadri M, Bonifati V. Genetics of movement disorders in the next-generation sequencing era. Mov Disord. 2016; 31: 458–70. DOI: 10.1002/mds.26521
    Back to article
  6. 6Singleton AB. Exome sequencing: A transformative technology. Lancet Neurol. 2011; 10: 942–6. DOI: 10.1016/S1474-4422(11)70196-X
    Back to article
  7. 7Malek N, Newman EJ. Hereditary chorea – what else to consider when the Huntington’s disease genetics test is negative? Acta Neurol Scand. 2017; 135: 25–33. DOI: 10.1111/ane.12609
    Back to article
  8. 8Mariani LL, Tesson C, Charles P, Cazeneuve C, Hahn V, Youssov K, et al. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach. JAMA Neurol. 2016; 73: 1105–14. DOI: 10.1001/jamaneurol.2016.2215
    Back to article
  9. 9Carapito R, Paul N, Untrau M, Le Gentil M, Ott L, Alsaleh G, et al. A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia. Mov Disord. 2015; 30: 423–7. DOI: 10.1002/mds.26115
    Back to article
  10. 10Hensman Moss DJ, Poulter M, Beck J, Hehir J, Polke JM, Campbell T, et al. C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. 2014; 82: 292–9. DOI: 10.1212/WNL.0000000000000061
    Back to article
  11. 11Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018; 14: 544–58. DOI: 10.1038/s41582-018-0047-2
    Back to article
  12. 12Martins J, Damasio J, Mendes A, Vila-Cha N, Alves JE, Ramos C, et al. Clinical spectrum of C9orf72 expansion in a cohort of Huntington’s disease phenocopies. Neurol Sci. 2018; 39: 741–4. DOI: 10.1007/s10072-018-3268-7
    Back to article
  13. 13Storey E. Genetic cerebellar ataxias. Semin Neurol. 2014; 34: 280–92. DOI: 10.1055/s-0034-1386766
    Back to article
  14. 14Stevanin G, Brice A. Spinocerebellar ataxia 17 (SCA17) and Huntington’s disease-like 4 (HDL4). Cerebellum. 2008; 7: 170–8. DOI: 10.1007/s12311-008-0016-1
    Back to article
  15. 15Loy CT, Sweeney MG, Davis MB, Wills AJ, Sawle GV, Lees AJ, et al. Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging. Mov Disord. 2005; 20: 1521–3. DOI: 10.1002/mds.20529
    Back to article
  16. 16Walker RH, Gatto EM, Bustamante ML, Bernal-Pacheco O, Cardoso F, Castilhos RM, et al. Huntington’s disease-like disorders in Latin America and the Caribbean. Parkinsonism Relat Disord. 2018; 53: 10–20. DOI: 10.1016/j.parkreldis.2018.05.021
    Back to article
  17. 17Walker RH, Jankovic J, O’Hearn E, Margolis RL. Phenotypic features of Huntington’s disease-like 2. Mov Disord. 2003; 18: 1527–30. DOI: 10.1002/mds.10587
    Back to article
  18. 18Anderson DG, Haagensen M, Ferreira-Correia A, Pierson R, Carr J, Krause A, et al. Emerging differences between Huntington’s disease-like 2 and Huntington’s disease: A comparison using MRI brain volumetry. Neuroimage Clin. 2019; 21: 101666. DOI: 10.1016/j.nicl.2019.101666
    Back to article
  19. 19Anderson DG, Walker RH, Connor M, Carr J, Margolis RL, Krause A. A Systematic Review of the Huntington Disease-Like 2 Phenotype. J Huntingtons Dis. 2017; 6: 37–46. DOI: 10.3233/JHD-160232
    Back to article
  20. 20Carroll LS, Massey TH, Wardle M, Peall KJ. Dentatorubral-pallidoluysian Atrophy: An Update. Tremor Other Hyperkinet Mov (N Y). 2018; 8: 577. DOI: 10.5334/tohm.439
    Back to article
  21. 21Tsuji S. Dentatorubral-pallidoluysian atrophy. Handb Clin Neurol. 2012; 103: 587–94. DOI: 10.1016/B978-0-444-51892-7.00041-3
    Back to article
  22. 22Hayflick SJ, Kurian MA, Hogarth P. Neurodegeneration with brain iron accumulation. Handb Clin Neurol. 2018; 147: 293–305. DOI: 10.1016/B978-0-444-63233-3.00019-1
    Back to article
  23. 23Dusek P, Jankovic J, Le W. Iron dysregulation in movement disorders. Neurobiol Dis. 2012; 46: 1–18. DOI: 10.1016/j.nbd.2011.12.054
    Back to article
  24. 24Baiardi S, Capellari S, Bartoletti Stella A, Parchi P. Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease. J Alzheimers Dis. 2018; 64: 1051–65. DOI: 10.3233/JAD-180123
    Back to article
  25. 25Govert F, Schneider SA. Huntington’s disease and Huntington’s disease-like syndromes: An overview. Curr Opin Neurol. 2013; 26: 420–7. DOI: 10.1097/WCO.0b013e3283632d90
    Back to article
  26. 26Schneider SA, Walker RH, Bhatia KP. The Huntington’s disease-like syndromes: what to consider in patients with a negative Huntington’s disease gene test. Nat Clin Pract Neurol. 2007; 3: 517–25. DOI: 10.1038/ncpneuro0606
    Back to article
  27. 27Tan AH, Toh TH, Low SC, Fong SL, Chong KK, Lee KW, et al. Chorea in Sporadic Creutzfeldt-Jakob Disease. J Mov Disord. 2018; 11: 149–51. DOI: 10.14802/jmd.18017
    Back to article
  28. 28Pedroso JL, de Freitas ME, Albuquerque MV, Saraiva-Pereira ML, Jardim LB, Barsottini OG. Should spinocerebellar ataxias be included in the differential diagnosis for Huntington’s diseases-like syndromes? Journal of the neurological sciences. 2014; 347: 356–8. DOI: 10.1016/j.jns.2014.09.050
    Back to article
  29. 29Perez Ortiz JM, Orr HT. Spinocerebellar Ataxia Type 1: Molecular Mechanisms of Neurodegeneration and Preclinical Studies. Adv Exp Med Biol. 2018; 1049: 135–45. DOI: 10.1007/978-3-319-71779-1_6
    Back to article
  30. 30Scoles DR, Pulst SM. Spinocerebellar Ataxia Type 2. Adv Exp Med Biol. 2018; 1049: 175–95. DOI: 10.1007/978-3-319-71779-1_8
    Back to article
  31. 31Paulson H. Machado-Joseph disease/spinocerebellar ataxia type 3. Handb Clin Neurol. 2012; 103: 437–49. DOI: 10.1016/B978-0-444-51892-7.00027-9
    Back to article
  32. 32Martino D, Stamelou M, Bhatia KP. The differential diagnosis of Huntington’s disease-like syndromes: ‘red flags’ for the clinician. Journal of neurology, neurosurgery, and psychiatry. 2013; 84: 650–6. DOI: 10.1136/jnnp-2012-302532
    Back to article
  33. 33Gupta A, Jankovic J. Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. Parkinsonism Relat Disord. 2009; 15: 621–6. DOI: 10.1016/j.parkreldis.2009.06.001
    Back to article
  34. 34Kim JS, Son TO, Youn J, Ki CS, Cho JW. Non-Ataxic Phenotypes of SCA8 Mimicking Amyotrophic Lateral Sclerosis and Parkinson Disease. J Clin Neurol. 2013; 9: 274–9. DOI: 10.3988/jcn.2013.9.4.274
    Back to article
  35. 35Groppo E, Armaroli A, Selvatici R, Gualandi F, Sensi M. Huntington’s disease-like presentation in Spinocerebellar ataxia type 12. Mov Disord. 2016; 31: 1248–9. DOI: 10.1002/mds.26679
    Back to article
  36. 36De Michele G, Lieto M, Galatolo D, Salvatore E, Cocozza S, Barghigiani M, et al. Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: A report of two Italian families. Parkinsonism Relat Disord. 2019; 65: 91–6. DOI: 10.1016/j.parkreldis.2019.05.001
    Back to article
  37. 37Ramos EM, Carecchio M, Lemos R, Ferreira J, Legati A, Sears RL, et al. Primary brain calcification: An international study reporting novel variants and associated phenotypes. Eur J Hum Genet. 2018; 26: 1462–77. DOI: 10.1038/s41431-018-0185-4
    Back to article
  38. 38Nicolas G, Pottier C, Charbonnier C, Guyant-Marechal L, Le Ber I, Pariente J, et al. Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain: A journal of neurology. 2013; 136: 3395–407. DOI: 10.1093/brain/awt255
    Back to article
  39. 39Fernandez M, Raskind W, Wolff J, Matsushita M, Yuen E, Graf W, et al. Familial dyskinesia and facial myokymia (FDFM): A novel movement disorder. Ann Neurol. 2001; 49: 486–92. DOI: 10.1002/ana.98
    Back to article
  40. 40Vijiaratnam N, Bhatia KP, Lang AE, Raskind WH, Espay AJ. ADCY5-Related Dyskinesia: Improving Clinical Detection of an Evolving Disorder. Mov Disord Clin Pract. 2019; 6: 512–20. DOI: 10.1002/mdc3.12816
    Back to article
  41. 41Chang FC, Westenberger A, Dale RC, Smith M, Pall HS, Perez-Duenas B, et al. Phenotypic insights into ADCY5-associated disease. Mov Disord. 2016; 31: 1033–40. DOI: 10.1002/mds.26598
    Back to article
  42. 42Mencacci NE, Erro R, Wiethoff S, Hersheson J, Ryten M, Balint B, et al. ADCY5 mutations are another cause of benign hereditary chorea. Neurology. 2015; 85: 80–8. DOI: 10.1212/WNL.0000000000001720
    Back to article
  43. 43Peall KJ, Kurian MA. Benign Hereditary Chorea: An Update. Tremor Other Hyperkinet Mov (N Y). 2015; 5: 314. DOI: 10.5334/tohm.269
    Back to article
  44. 44Kumar G, Dixon A. Benign hereditary chorea: A case report and brief review of inherited choreas. Pediatr Neurol. 2014; 51: 532–6. DOI: 10.1016/j.pediatrneurol.2014.06.001
    Back to article
  45. 45Parnes M, Bashir H, Jankovic J. Is Benign Hereditary Chorea Really Benign? Brain-Lung-Thyroid Syndrome Caused by NKX2-1 Mutations. Mov Disord Clin Pract. 2019; 6: 34–9. DOI: 10.1002/mdc3.12690
    Back to article
  46. 46Gras D, Jonard L, Roze E, Chantot-Bastaraud S, Koht J, Motte J, et al. Benign hereditary chorea: Phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene. Journal of neurology, neurosurgery, and psychiatry. 2012; 83: 956–62. DOI: 10.1136/jnnp-2012-302505
    Back to article
  47. 47Remerand G, Boespflug-Tanguy O, Tonduti D, Touraine R, Rodriguez D, Curie A, et al. Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations. Dev Med Child Neurol. 2019; 61: 1439–47. DOI: 10.1111/dmcn.14332
    Back to article
  48. 48Wright RA, Pollock M, Donaldson IM. Chorea and tuberous sclerosis. Mov Disord. 1992; 7: 87–9. DOI: 10.1002/mds.870070119
    Back to article
  49. 49Ferlazzo E, Gasparini S, Gambardella A, Labate A, Cianci V, Cherubini A, et al. Unilateral basal ganglia atrophy in a patient with tuberous sclerosis complex and hemichorea. Mov Disord. 2012; 27: 458–60. DOI: 10.1002/mds.24014
    Back to article
  50. 50Peikert K, Danek A, Hermann A. Current state of knowledge in Chorea-Acanthocytosis as core Neuroacanthocytosis syndrome. Eur J Med Genet. 2017. DOI: 10.1016/j.ejmg.2017.12.007
    Back to article
  51. 51Filla A, De Michele G, Coppola G, Federico A, Vita G, Toscano A, et al. Accuracy of clinical diagnostic criteria for Friedreich’s ataxia. Mov Disord. 2000; 15: 1255–8. DOI: 10.1002/1531-8257(200011)15:6<;1255::AID-MDS1031>3.0.CO;2-C
    Back to article
  52. 52Cook A, Giunti P. Friedreich’s ataxia: Clinical features, pathogenesis and management. Br Med Bull. 2017; 124: 19–30. DOI: 10.1093/bmb/ldx034
    Back to article
  53. 53Zhu D, Burke C, Leslie A, Nicholson GA. Friedreich’s ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion. Mov Disord. 2002; 17: 585–9. DOI: 10.1002/mds.10175
    Back to article
  54. 54Hanna MG, Davis MB, Sweeney MG, Noursadeghi M, Ellis CJ, Elliot P, et al. Generalized chorea in two patients harboring the Friedreich’s ataxia gene trinucleotide repeat expansion. Mov Disord. 1998; 13: 339–40. DOI: 10.1002/mds.870130223
    Back to article
  55. 55Kang HG, Kim M, Lee SC. Aceruloplasminemia With Positive Ceruloplasm Gene Mutation. JAMA Ophthalmol. 2016; 134: e160816. DOI: 10.1001/jamaophthalmol.2016.0816
    Back to article
  56. 56Kambouris M, Bohlega S, Al-Tahan A, Meyer BF. Localization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p15.3. Am J Hum Genet. 2000; 66: 445–52. DOI: 10.1086/302744
    Back to article
  57. 57Mulligan C, Bronstein JM. Wilson Disease: An Overview and Approach to Management. Neurol Clin. 2020; 38: 417–32. DOI: 10.1016/j.ncl.2020.01.005
    Back to article
  58. 58Yu XE, Gao S, Yang RM, Han YZ. MR Imaging of the Brain in Neurologic Wilson Disease. AJNR Am J Neuroradiol. 2019; 40: 178–83. DOI: 10.3174/ajnr.A5936
    Back to article
  59. 59Bandmann O, Weiss KH, Kaler SG. Wilson’s disease and other neurological copper disorders. Lancet Neurol. 2015; 14: 103–13. DOI: 10.1016/S1474-4422(14)70190-5
    Back to article
  60. 60Teive HA, Moro A, Moscovich M, Arruda WO, Munhoz RP, Raskin S, et al. Ataxia-telangiectasia – A historical review and a proposal for a new designation: ATM syndrome. Journal of the neurological sciences. 2015; 355: 3–6. DOI: 10.1016/j.jns.2015.05.022
    Back to article
  61. 61Synofzik M, Nemeth AH. Recessive ataxias. Handb Clin Neurol. 2018; 155: 73–89. DOI: 10.1016/B978-0-444-64189-2.00005-6
    Back to article
  62. 62Fink JK. Hereditary spastic paraplegia: Clinical principles and genetic advances. Semin Neurol. 2014; 34: 293–305. DOI: 10.1055/s-0034-1386767
    Back to article
  63. 63Garcia-Moreno H, Fassihi H, Sarkany RPE, Phukan J, Warner T, Lehmann AR, et al. Xeroderma pigmentosum is a definite cause of Huntington’s disease-like syndrome. Ann Clin Transl Neurol. 2018; 5: 102–8. DOI: 10.1002/acn3.511
    Back to article
  64. 64Carecchio M, Mencacci NE. Emerging Monogenic Complex Hyperkinetic Disorders. Current neurology and neuroscience reports. 2017; 17: 97. DOI: 10.1007/s11910-017-0806-2
    Back to article
  65. 65Skorvanek M, Dusek P, Rydzanicz M, Walczak A, Kosinska J, Kostrzewa G, et al. Neurodevelopmental disorder associated with IRF2BPL gene mutation: Expanding the phenotype? Parkinsonism Relat Disord. 2019; 62: 239–41.
    Back to article
  66. 66Roulis E, Hyland C, Flower R, Gassner C, Jung HH, Frey BM. Molecular Basis and Clinical Overview of McLeod Syndrome Compared With Other Neuroacanthocytosis Syndromes: A Review. JAMA Neurol. 2018. DOI: 10.1001/jamaneurol.2018.2166
    Back to article
  67. 67Osorio MJ, Goldman SA. Neurogenetics of Pelizaeus-Merzbacher disease. Handb Clin Neurol. 2018; 148: 701–22. DOI: 10.1016/B978-0-444-64076-5.00045-4
    Back to article
  68. 68Rodriguez-Quiroga S, Zavala L, Perez Maturo J, Gonzalez-Moron D, Garretto N, Kauffman MA. A Family with Late-Onset and Predominant Choreic Niemann Pick Type C: A Treatable Piece in the Etiological Puzzle of Choreas. Mov Disord Clin Pract. 2020; 7: 332–4. DOI: 10.1002/mdc3.12920
    Back to article
  69. 69Christensen CK, Walsh L. Movement Disorders and Neurometabolic Diseases. Semin Pediatr Neurol. 2018; 25: 82–91. DOI: 10.1016/j.spen.2018.02.003
    Back to article
  70. 70Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, et al. Treatable inherited rare movement disorders. Mov Disord. 2018; 33: 21–35. DOI: 10.1002/mds.27140
    Back to article
  71. 71Ferreira CR, Cassiman D, Blau N. Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases. Mol Genet Metab. 2019; 127: 117–21. DOI: 10.1016/j.ymgme.2019.04.002
    Back to article
  72. 72Ebrahimi-Fakhari D, Van Karnebeek C, Munchau A. Movement Disorders in Treatable Inborn Errors of Metabolism. Mov Disord. 2019; 34: 598–613. DOI: 10.1002/mds.27568
    Back to article
  73. 73Magner M, Kolarova H, Honzik T, Svandova I, Zeman J. Clinical manifestation of mitochondrial diseases. Dev Period Med. 2015; 19: 441–9.
    Back to article
  74. 74Ghaoui R, Sue CM. Movement disorders in mitochondrial disease. J Neurol. 2018; 265: 1230–40. DOI: 10.1007/s00415-017-8722-6
    Back to article
  75. 75Tranchant C, Anheim M. Movement disorders in mitochondrial diseases. Rev Neurol (Paris). 2016; 172: 524–9. DOI: 10.1016/j.neurol.2016.07.003
    Back to article
  76. 76Pearson TS, Pons R, Ghaoui R, Sue CM. Genetic mimics of cerebral palsy. Mov Disord. 2019; 34: 625–36. DOI: 10.1002/mds.27655
    Back to article
  77. 77Mullin PJ, Kershaw PW, Bolt JM. Choreoathetotic movement disorder in alcoholism. Br Med J. 1970; 4: 278–81. DOI: 10.1136/bmj.4.5730.278
    Back to article
  78. 78Hung SC, Hung SH, Tarng DC, Yang WC, Huang TP. Chorea induced by thiamine deficiency in hemodialysis patients. Am J Kidney Dis. 2001; 37: 427–30. DOI: 10.1053/ajkd.2001.21337
    Back to article
  79. 79Miyasaki JM. Chorea caused by toxins. Handb Clin Neurol. 2011; 100: 335–46. DOI: 10.1016/B978-0-444-52014-2.00026-4
    Back to article
  80. 80de Lacerda JF, Oliveira SN, Ferro JM. Chronic myeloproliferative diseases. Handb Clin Neurol. 2014; 120: 1073–81. DOI: 10.1016/B978-0-7020-4087-0.00072-3
    Back to article
  81. 81Venkatesan EP, Ramadoss K, Balakrishnan R, Prakash B. Essential thrombocythemia: Rare cause of chorea. Ann Indian Acad Neurol. 2014; 17: 106–7. DOI: 10.4103/0972-2327.128569
    Back to article
  82. 82O’Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, et al. Autoimmune chorea in adults. Neurology. 2013; 80: 1133–44. DOI: 10.1212/WNL.0b013e3182886991
    Back to article
  83. 83Maciel RO, Ferreira GA, Akemy B, Cardoso F. Executive dysfunction, obsessive-compulsive symptoms, and attention deficit and hyperactivity disorder in Systemic Lupus Erythematosus: Evidence for basal ganglia dysfunction? Journal of the neurological sciences. 2016; 360: 94–7. DOI: 10.1016/j.jns.2015.11.052
    Back to article
  84. 84Baizabal-Carvallo JF, Jankovic J. Autoimmune and paraneoplastic movement disorders: An update. Journal of the neurological sciences. 2018; 385: 175–84. DOI: 10.1016/j.jns.2017.12.035
    Back to article
  85. 85Cardoso F. Autoimmune choreas. Journal of neurology, neurosurgery, and psychiatry. 2017; 88: 412–7. DOI: 10.1136/jnnp-2016-314475
    Back to article
  86. 86Baizabal-Carvallo JF, Stocco A, Muscal E, Jankovic J. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord. 2013; 28: 543–7. DOI: 10.1002/mds.25354
    Back to article
  87. 87Baizabal-Carvallo JF, Jankovic J. Movement disorders in autoimmune diseases. Mov Disord. 2012; 27: 935–46. DOI: 10.1002/mds.25011
    Back to article
  88. 88Dale RC. Immune-mediated extrapyramidal movement disorders, including Sydenham chorea. Handb Clin Neurol. 2013; 112: 1235–41. DOI: 10.1016/B978-0-444-52910-7.00046-5
    Back to article
  89. 89Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016; 15: 391–404. DOI: 10.1016/S1474-4422(15)00401-9
    Back to article
  90. 90Dalmau J, Graus F. Antibody-Mediated Encephalitis. N Engl J Med. 2018; 378: 840–51. DOI: 10.1056/NEJMra1708712
    Back to article
  91. 91Delangle R, Demeret S, Canlorbe G, Chelon L, Belghiti J, Gonthier C, et al. Anti-NMDA receptor encephalitis associated with ovarian tumor: The gynecologist point of view. Arch Gynecol Obstet. 2020. DOI: 10.1007/s00404-020-05645-9
    Back to article
  92. 92Nair JR, Moots RJ. Behcet’s disease. Clin Med (Lond). 2017; 17: 71–7. DOI: 10.7861/clinmedicine.17-1-71
    Back to article
  93. 93Sorgun MH, Kural MA, Yucesan C. Clinical characteristics and prognosis of Neuro-Behcet’s disease. Eur J Rheumatol. 2018; 5: 235–9. DOI: 10.5152/eurjrheum.2018.18033
    Back to article
  94. 94Uygunoglu U, Siva A. Nervous system involvement in Behcet’s syndrome. Curr Opin Rheumatol. 2019; 31: 32–9. DOI: 10.1007/978-3-030-19515-1_22
    Back to article
  95. 95Rizzo G, Licchetta L, Scaglione C, Buttiglione M, Capellari S, Martinelli P, et al. Behcet disease presenting with movement disorders and antibasal ganglia antibodies. Autoimmun Rev. 2016; 15: 287–8. DOI: 10.1016/j.autrev.2015.11.011
    Back to article
  96. 96Min JH, Youn YC. Bilateral basal ganglia lesions of primary Sjogren syndrome presenting with generalized chorea. Parkinsonism Relat Disord. 2009; 15: 398–9. DOI: 10.1016/j.parkreldis.2008.06.007
    Back to article
  97. 97Santosa A, Lim AY, Vasoo S, Lau TC, Teng GG. Neurosjogren: Early therapy is associated with successful outcomes. J Clin Rheumatol. 2012; 18: 389–92. DOI: 10.1097/RHU.0b013e318277369e
    Back to article
  98. 98Leonard MM, Sapone A, Catassi C, Fasano A. Celiac Disease and Nonceliac Gluten Sensitivity: A Review. JAMA. 2017; 318: 647–56. DOI: 10.1001/jama.2017.9730
    Back to article
  99. 99Andrade C, Rocha H, Albuquerque A, Sa MJ. Gluten chorea. Clin Neurol Neurosurg. 2015; 138: 8–9. DOI: 10.1016/j.clineuro.2015.07.009
    Back to article
  100. 100Walker RH. Further Evidence for Celiac Disease-associated Chorea. Tremor Other Hyperkinet Mov (N Y). 2011; 1. DOI: 10.5334/tohm.80
    Back to article
  101. 101Gaig C, Graus F, Compta Y, Hogl B, Bataller L, Bruggemann N, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology. 2017; 88: 1736–43. DOI: 10.1212/WNL.0000000000003887
    Back to article
  102. 102Cunningham MW, Cox CJ. Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond. Acta Physiol (Oxf). 2016; 216: 90–100. DOI: 10.1111/apha.12614
    Back to article
  103. 103Balint B, Bhatia KP. Stiff person syndrome and other immune-mediated movement disorders – new insights. Curr Opin Neurol. 2016; 29: 496–506. DOI: 10.1097/WCO.0000000000000351
    Back to article
  104. 104Dalmau J, Geis C, Graus F. Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physiol Rev. 2017; 97: 839–87. DOI: 10.1152/physrev.00010.2016
    Back to article
  105. 105Docherty MJ, Burn DJ. Hyperthyroid chorea. Handb Clin Neurol. 2011; 100: 279–86. DOI: 10.1016/B978-0-444-52014-2.00020-3
    Back to article
  106. 106Leblicq C, Duval M, Carmant L, Van Vliet G, Alos N. Rising serum thyroxine levels and chorea in graves’ disease. Pediatrics. 2013; 131: e616–9. DOI: 10.1542/peds.2012-0686
    Back to article
  107. 107Cardoso F, Seppi K, Mair KJ, Wenning GK, Poewe W. Seminar on choreas. Lancet Neurol. 2006; 5: 589–602. DOI: 10.1016/S1474-4422(06)70494-X
    Back to article
  108. 108Jin D, Yoon WT, Suh BC, Moon HS, Chung PW, Kim YB. Exacerbation of idiopathic paroxysmal kinesigenic dyskinesia in remission state caused by secondary hypoparathyroidism with hypocalcemia after thyroidectomy: Evidence for ion channelopathy. Brain Dev. 2012; 34: 840–3. DOI: 10.1016/j.braindev.2012.01.014
    Back to article
  109. 109Howdle PD, Bone I, Losowsky MS. Hypocalcaemic chorea secondary to malabsorption. Postgrad Med J. 1979; 55: 560–3. DOI: 10.1136/pgmj.55.646.560
    Back to article
  110. 110Warren JD, Kimber TE, Thompson PD. Hypocalcaemic chorea secondary to malabsorption. Aust N Z J Med. 1998; 28: 343. DOI: 10.1111/j.1445-5994.1998.tb01959.x
    Back to article
  111. 111Topakian R, Stieglbauer K, Rotaru J, Haring HP, Aichner FT, Pichler R. Hypocalcemic choreoathetosis and tetany after bisphosphonate treatment. Mov Disord. 2006; 21: 2026–7. DOI: 10.1002/mds.21094
    Back to article
  112. 112Sparacio RR, Anziska B, Schutta HS. Hypernatremia and chorea. A report of two cases. Neurology. 1976; 26: 46–50. DOI: 10.1212/WNL.26.1.46
    Back to article
  113. 113Alarcon F, Maldonado JC, Rivera JW. Movement disorders identified in patients with intracranial tuberculomas. Neurologia. 2011; 26: 343–50. DOI: 10.1016/S2173-5808(11)70080-3
    Back to article
  114. 114Ezpeleta D, de Andres C, Gimenez-Roldan S. Abnormal movements in a case of extrapontine myelinolysis. Review of the literature. Rev Neurol. 1998; 26: 215–20. DOI: 10.33588/rn.26150.981060
    Back to article
  115. 115Ravindran T, Paneerselvam, Radha, Yabesh TA. Osmotic Demyelination Syndrome Presenting with Chorea. J Assoc Physicians India. 2016; 64: 89–90.
    Back to article
  116. 116Tison FX, Ferrer X, Julien J. Delayed onset movement disorders as a complication of central pontine myelinolysis. Mov Disord. 1991; 6: 171–3. DOI: 10.1002/mds.870060215
    Back to article
  117. 117Kim YJ, Kim SJ, Kim J, Kim MJ, Kim KJ, Yoon H, et al. Chorea due to diabetic hyperglycemia and uremia: Distinct clinical and imaging features. Mov Disord. 2015; 30: 419–22. DOI: 10.1002/mds.26148
    Back to article
  118. 118Hamed SA. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: Presentations, causes and treatment strategies. Expert Rev Clin Pharmacol. 2018. DOI: 10.1080/17512433.2019.1555468
    Back to article
  119. 119Pigoni A, Iuculano F, Saetti C, Airaghi L, Burdick L, Spreafico S, et al. Acquired hepatocerebral degeneration (AHD): A peculiar neurological impairment in advanced chronic liver disease. Metab Brain Dis. 2018; 33: 347–52. DOI: 10.1007/s11011-017-0107-0
    Back to article
  120. 120Shin HW, Park HK. Recent Updates on Acquired Hepatocerebral Degeneration. Tremor Other Hyperkinet Mov (N Y). 2017; 7: 463. DOI: 10.5334/tohm.379
    Back to article
  121. 121Bateman JR, Roque DA. Teaching NeuroImages: Acquired hepatocerebral degeneration: An underrecognized complication of advanced liver disease. Neurology. 2016; 87: e144. DOI: 10.1212/WNL.0000000000003153
    Back to article
  122. 122Przekop A, Sanger TD. Birth-related syndromes of athetosis and kernicterus. Handb Clin Neurol. 2011; 100: 387–95. DOI: 10.1016/B978-0-444-52014-2.00030-6
    Back to article
  123. 123Netravathi M, Pal PK, Indira Devi B. A clinical profile of 103 patients with secondary movement disorders: correlation of etiology with phenomenology. Eur J Neurol. 2012; 19: 226–33. DOI: 10.1111/j.1468-1331.2011.03469.x
    Back to article
  124. 124Rose J, Vassar R. Movement disorders due to bilirubin toxicity. Semin Fetal Neonatal Med. 2015; 20: 20–5. DOI: 10.1016/j.siny.2014.11.002
    Back to article
  125. 125Natera-Villalba E, Estevez-Fraga C, Sanchez-Herrera FA, Ruiz-Gomez F, Sanz BZ, Canovas AA, et al. Simultaneous acute presentation of generalized chorea and subacute combined degeneration secondary to vitamin B12 deficiency. Parkinsonism Relat Disord. 2018; 55: 2–4. DOI: 10.1016/j.parkreldis.2018.09.006
    Back to article
  126. 126Wolffenbuttel BHR, Wouters H, Heiner-Fokkema MR, van der Klauw MM. The Many Faces of Cobalamin (Vitamin B12) Deficiency. Mayo Clin Proc Innov Qual Outcomes. 2019; 3: 200–14. DOI: 10.1016/j.mayocpiqo.2019.03.002
    Back to article
  127. 127Edvardsson B, Persson S. Chorea associated with vitamin B12 deficiency. Eur J Neurol. 2011; 18: e138–9. DOI: 10.1111/j.1468-1331.2011.03478.x
    Back to article
  128. 128Sabatini JS, Schutz-Pereira GL, Feltrin F, Teive HAG, Camargo CHF. Wernicke’s encephalopathy with chorea: Neuroimaging findings. Dement Neuropsychol. 2016; 10: 370–2. DOI: 10.1590/s1980-5764-2016dn1004020
    Back to article
  129. 129Tranchant C, Bhatia KP, Marsden CD. Movement disorders in multiple sclerosis. Mov Disord. 1995; 10: 418–23. DOI: 10.1002/mds.870100403
    Back to article
  130. 130Deuschl G. Movement disorders in multiple sclerosis and their treatment. Neurodegener Dis Manag. 2016; 6: 31–5. DOI: 10.2217/nmt-2016-0053
    Back to article
  131. 131Mehanna R, Jankovic J. Movement disorders in multiple sclerosis and other demyelinating diseases. Journal of the neurological sciences. 2013; 328: 1–8. DOI: 10.1016/j.jns.2013.02.007
    Back to article
  132. 132Vigliani MC, Honnorat J, Antoine JC, Vitaliani R, Giometto B, Psimaras D, et al. Chorea and related movement disorders of paraneoplastic origin: The PNS EuroNetwork experience. J Neurol. 2011; 258: 2058–68. DOI: 10.1007/s00415-011-6074-1
    Back to article
  133. 133Lancaster E. Paraneoplastic disorders. Continuum (Minneap Minn). 2015; 21: 452–75. DOI: 10.1212/01.CON.0000464180.89580.88
    Back to article
  134. 134Chang K, Lwanga A, Kaur T, Helgason C. P/Q and N-type Voltage-gated Calcium Channel Binding Antibodies Associated with Paraneoplastic Chorea and Mixed Invasive Ductal and Lobular Carcinoma of the Breasts in an Elderly Patient. Cureus. 2018; 10: e3097. DOI: 10.7759/cureus.3097
    Back to article
  135. 135Mehta SH, Morgan JC, Sethi KD. Paraneoplastic movement disorders. Current neurology and neuroscience reports. 2009; 9: 285–91. DOI: 10.1007/s11910-009-0043-4
    Back to article
  136. 136Harish R, Sharma DB. Chorea–a rare complication of enteric fever. Indian Pediatr. 1993; 30: 428–9.
    Back to article
  137. 137Bamford JM, Hakin RN. Chorea after legionnaire’s disease. Br Med J (Clin Res Ed). 1982; 284: 1232–3. DOI: 10.1136/bmj.284.6324.1232
    Back to article
  138. 138Alarcon F, Duenas G, Cevallos N, Lees AJ. Movement disorders in 30 patients with tuberculous meningitis. Mov Disord. 2000; 15: 561–9. DOI: 10.1002/1531-8257(200005)15:3<;561::AID-MDS1021>3.0.CO;2-K
    Back to article
  139. 139Pinto MV, Aguiar T, Nogueira R, Dias AC, Rosso AL. Hemichorea in tuberculous meningitis. Arq Neuropsiquiatr. 2014; 72: 254. DOI: 10.1590/0004-282X20130230
    Back to article
  140. 140Beskind DL, Keim SM. Choreoathetotic movement disorder in a boy with Mycoplasma pneumoniae encephalitis. Ann Emerg Med. 1994; 23: 1375–8. DOI: 10.1016/S0196-0644(94)70365-5
    Back to article
  141. 141Cubo E. Movement disorders in adult-onset measles encephalitis. Neurologia. 2003; 18: 30–3.
    Back to article
  142. 142Hammann KP, Henkel B, Erbel R, Kramer G. Hemichorea associated with varicella-zoster reinfection and endocarditis. A case report. Eur Arch Psychiatry Neurol Sci. 1985; 234: 404–7. DOI: 10.1007/BF00386059
    Back to article
  143. 143Prasuhn J, Royl G, Wandinger KP, Bruggemann N, Neumann A, Munte TF. Transient Generalized Chorea in Influenza A Encephalopathy. Tremor Other Hyperkinet Mov (N Y). 2018; 8: 591. DOI: 10.5334/tohm.422
    Back to article
  144. 144Peters AC, Vielvoye GJ, Versteeg J, Bots GT, Lindeman J. ECHO 25 focal encephalitis and subacute hemichorea. Neurology. 1979; 29: 676–81. DOI: 10.1212/WNL.29.5.676
    Back to article
  145. 145Wang HS, Kuo MF, Huang SC, Chou ML. Choreoathetosis as an initial sign of relapsing of herpes simplex encephalitis. Pediatr Neurol. 1994; 11: 341–5. DOI: 10.1016/0887-8994(94)90014-0
    Back to article
  146. 146Leavell R, Ray CG, Ferry PC, Minnich LL. Unusual acute neurologic presentations with Epstein-Barr virus infection. Arch Neurol. 1986; 43: 186–8. DOI: 10.1001/archneur.1986.00520020072025
    Back to article
  147. 147Basumatary LJ, Raja D, Bhuyan D, Das M, Goswami M, Kayal AK. Clinical and radiological spectrum of Japanese encephalitis. Journal of the neurological sciences. 2013; 325: 15–21. DOI: 10.1016/j.jns.2012.11.007
    Back to article
  148. 148Zajkowska J, Moniuszko A, Czupryna P, Drozdowski W, Krupa W, Guziejko K, et al. Chorea and tick-borne encephalitis, Poland. Emerg Infect Dis. 2013; 19: 1544–5. DOI: 10.3201/eid1909.130804
    Back to article
  149. 149Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism. Biochim Biophys Acta. 2009; 1792: 714–21. DOI: 10.1016/j.bbadis.2008.08.001
    Back to article
  150. 150Carroll E, Sanchez-Ramos J. Hyperkinetic movement disorders associated with HIV and other viral infections. Handb Clin Neurol. 2011; 100: 323–34. DOI: 10.1016/B978-0-444-52014-2.00025-2
    Back to article
  151. 151Ozben S, Erol C, Ozer F, Tiras R. Chorea as the presenting feature of neurosyphilis. Neurol India. 2009; 57: 347–9. DOI: 10.4103/0028-3886.53277
    Back to article
  152. 152Martinelli P, Rizzo G, Scaglione C, Capellari S. Neurosyphilis orofacial dyskinesia: The candy sign. Mov Disord. 2013; 28: 246–7. DOI: 10.1002/mds.25281
    Back to article
  153. 153Piccolo I, Thiella G, Sterzi R, Colombo N, Defanti CA. Chorea as a symptom of neuroborreliosis: A case study. Ital J Neurol Sci. 1998; 19: 235–9. DOI: 10.1007/BF02427611
    Back to article
  154. 154Curless RG, Katz DA, Perryman RA, Ferrer PL, Gelblum J, Weiner WJ. Choreoathetosis after surgery for congenital heart disease. J Pediatr. 1994; 124: 737–9. DOI: 10.1016/S0022-3476(05)81365-4
    Back to article
  155. 155Kirkham FJ, Haywood P, Kashyape P, Borbone J, Lording A, Pryde K, et al. Movement disorder emergencies in childhood. Eur J Paediatr Neurol. 2011; 15: 390–404. DOI: 10.1016/j.ejpn.2011.04.005
    Back to article
  156. 156Iriarte LM, Mateu J, Cruz G, Escudero J. Chorea: A new manifestation of mastocytosis. Journal of neurology, neurosurgery, and psychiatry. 1988; 51: 1457–8. DOI: 10.1136/jnnp.51.11.1457-a
    Back to article
  157. 157Kanekura T, Sekiyama M, Mochitomi Y, Mera Y, Takeda K, Kanzaki T. A case of mastocytosis with chorea. J Dermatol. 2001; 28: 451–2. DOI: 10.1111/j.1346-8138.2001.tb00009.x
    Back to article
  158. 158Baker JM, Hung AY. Movement Disorders in Women. Semin Neurol. 2017; 37: 653–60. DOI: 10.1055/s-0037-1608845
    Back to article
  159. 159Robottom BJ, Weiner WJ. Chorea gravidarum. Handb Clin Neurol. 2011; 100: 231–5. DOI: 10.1016/B978-0-444-52014-2.00015-X
    Back to article
DOI: https://doi.org/10.5334/tohm.548 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Jul 6, 2020
Accepted on: Jul 9, 2020
Published on: Aug 6, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Rare disease,
orphan disease,
inherited disease,
treatment

© 2020 Daniel Martinez-Ramirez, Ruth H. Walker, Mayela Rodriguez-Violante, Emilia M. Gatto, on behalf of the Rare Movement Disorders Study Group of International Parkinson’s Disease and Movement Disorders Society, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 10 (2020): Issue 0Next article